MADRIGAL PHARMACEUTICALS, INC. (MDGL)
MADRIGAL PHARMACEUTICALS, INC. filed 28 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 8 reporting owners, covering 254 transactions and 419,630 shares. None carries the SEC's AFF10B5ONE flag; all 28 name a plan in a footnote. 8 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-09-11, came 102 days after the one before it (2026-06-01) and reports 24 transactions against 1 in the filing before it.
- The sales it reports total 11,583 shares, 10,541 more than the 1,042 in the filing before it.
- Its 28 plan statements rank 214th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 3 have more plan statements on file than it and 7 have fewer.
- Its 28 filings on file run from 2025-03-05 to 2026-09-11, and state 11 plan adoption dates, from 2024-11-05 to 2026-06-05.
Trades in MADRIGAL PHARMACEUTICALS, INC. 254
- Dier Mardi — 2025-03-03 · S · 1,187 shares
- Dier Mardi — 2025-03-03 · S · 774 shares
- Huntsman Carole — 2025-03-03 · S · 71 shares
- Huntsman Carole — 2025-03-03 · S · 200 shares
- Huntsman Carole — 2025-03-03 · S · 300 shares
- Huntsman Carole — 2025-03-03 · S · 200 shares
- Huntsman Carole — 2025-03-03 · S · 200 shares
- Huntsman Carole — 2025-03-03 · S · 100 shares
- Huntsman Carole — 2025-03-03 · S · 100 shares
- Huntsman Carole — 2025-03-03 · S · 100 shares
- Huntsman Carole — 2025-03-03 · S · 563 shares
- Kelley Shannon T — 2025-03-03 · S · 415 shares
Adoption dates in MADRIGAL PHARMACEUTICALS, INC. 11
- 2024-11-05 — stated in 3 filings
- 2024-11-07 — stated in 3 filings
- 2024-11-13 — stated in 2 filings
- 2024-11-15 — stated in 1 filing
- 2025-03-14 — stated in 7 filings
- 2025-08-14 — stated in 1 filing
- 2025-09-02 — stated in 2 filings
- 2025-09-10 — stated in 6 filings
- 2026-02-20 — stated in 1 filing
- 2026-03-02 — stated in 1 filing
- 2026-06-05 — stated in 1 filing
Results prints in MADRIGAL PHARMACEUTICALS, INC. 8
- 2025-01-13
- 2025-02-26
- 2025-05-01
- 2025-08-05
- 2025-11-04
- 2026-02-19
- 2026-05-06
- 2026-07-30
Trades before a print in MADRIGAL PHARMACEUTICALS, INC. 0
- 18 days before the 2025-08-05 print — 2025-07-18 · S · FRIEDMAN PAUL A · 1,400 shares
- 18 days before the 2025-08-05 print — 2025-07-18 · S · Taub Rebecca · 1,000 shares
- 19 days before the 2025-08-05 print — 2025-07-17 · S · FRIEDMAN PAUL A · 2,000 shares
- 19 days before the 2025-08-05 print — 2025-07-17 · S · FRIEDMAN PAUL A · 700 shares
- 19 days before the 2025-08-05 print — 2025-07-17 · S · Taub Rebecca · 2,057 shares
- 19 days before the 2025-08-05 print — 2025-07-17 · S · Taub Rebecca · 600 shares
- 20 days before the 2025-08-05 print — 2025-07-16 · S · FRIEDMAN PAUL A · 5,541 shares
- 20 days before the 2025-08-05 print — 2025-07-16 · S · FRIEDMAN PAUL A · 2,371 shares
- 20 days before the 2025-08-05 print — 2025-07-16 · S · FRIEDMAN PAUL A · 2,110 shares
- 20 days before the 2025-08-05 print — 2025-07-16 · S · FRIEDMAN PAUL A · 2,319 shares
- 20 days before the 2025-08-05 print — 2025-07-16 · S · FRIEDMAN PAUL A · 6,851 shares
- 20 days before the 2025-08-05 print — 2025-07-16 · S · FRIEDMAN PAUL A · 5,784 shares
Interval to MADRIGAL PHARMACEUTICALS, INC.’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 0within 10 days
- 18shortest, days
- 24no later print
Adoption dates MADRIGAL PHARMACEUTICALS, INC. states
- 2024-11-05 in 3 filings
- 2024-11-07 in 3 filings
- 2024-11-13 in 2 filings
- 2024-11-15 in 1 filing
- 2025-03-14 in 7 filings
- 2025-08-14 in 1 filing
- 2025-09-02 in 2 filings
- 2025-09-10 in 6 filings
- 2026-02-20 in 1 filing
- 2026-03-02 in 1 filing
- 2026-06-05 in 1 filing
Filing text: “10b5-1 trading plan adopted by the Reporting Person on March 14, 2025”
Reported results dates on file
- 2025-01-13
- 2025-02-26
- 2025-05-01
- 2025-08-05
- 2025-11-04
- 2026-02-19
- 2026-05-06
- 2026-07-30
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.
The address of this record
MADRIGAL PHARMACEUTICALS, INC.’s insider trading plan record — 28 Form 4 statements in the 2025 filing year — is published at one address, this page. When you cite or link the record, use https://velarionrecords.com/plan10b5/issuer/0001157601.